Mostrando 10 resultados de: 10
Filtros aplicados
Subtipo de publicación
Article(10)
Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153 152 middle-aged individuals
ArticleAbstract: Aims: To compare the prevalence of electrocardiogram (ECG)-documented atrial fibrillation (or fluttePalabras claves:Atrial Fibrillation, CLSA, epidemiologyAutores:Alhabib K.F., Avezum A.J., Bahonar A., Chifamba J., Connolly S.J., Dagenais G.R., Dans A.M., Douma R., Gupta R., Healey J.S., Huisman H., Ibrahim Q., Islam S., Ismail R., Iype T., Joseph P.G., Kazmi K., Kengne A.P., Keskinler M.V., Kumar R., Lanas F.T., Lear S.A., Mohan V., Mony P.K., Orlandini A., PATRICIO LOPEZ -JARAMILLO, Rahman O., Raina P., Rangarajan S., Rosengren A., Teo K.K., Wei L., Yeates K.E., Yusuf S., Yusufali A.M., Zatońska K.Fuentes:googlescopusFixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis
ArticleAbstract: Background: In randomised controlled trials, fixed-dose combination treatments (or polypills) have bPalabras claves:Autores:Avezum A.J., Bangdiwala S.I., Bosch J.J., Castellano J.M., Dagenais G.R., Dans A.M., DIaz R., Fuster V., Gamra H., Gao P., Huffman M.D., Joseph P.G., Liu L., Lonn E.M., Malekzadeh R., Pais P., PATRICIO LOPEZ -JARAMILLO, Prabhakaran D., Rodgers A., Roshandel G., Sliwa K., Teo K.K., Xavier D., Yusuf S., Zhu J.Fuentes:googlescopusEffects of a Polypill, Aspirin, and the Combination of Both on Cognitive and Functional Outcomes: A Randomized Clinical Trial
ArticleAbstract: Importance: Vascular risk factors are associated with cognitive decline but studies addressing indivPalabras claves:Autores:Bosch J.J., Dans A.M., Gao P., Joseph P.G., O'donnell M.J., Pais P., PATRICIO LOPEZ -JARAMILLO, Xavier D., Yusuf S.Fuentes:scopusHealth-Related Quality of Life and Mortality in Heart Failure The Global Congestive Heart Failure Study of 23000 Patients From 40 Countries
ArticleAbstract: BACKGROUND: Poor health-related quality of life (HRQL) is common in heart failure (HF), but there arPalabras claves:health status, Heart Failure, Left, prognosis, quality of life, Ventricular functionAutores:Alhabib K.F., Balasubramanian K., Bayes-Genis A., Budaj A.J., Dans A.M., Dokainish H., Dzudie A., Ezekowitz J.A., Fox K.A.A., Fukakusa B., Grinvalds A., Johansson I., Joseph P.G., Kamath D., Karaye K.M., Lanas F.T., Lund L.H., Maggioni A.P., Makubi A., McCready T., McMurray J.J.V., PATRICIO LOPEZ -JARAMILLO, Probstfield J.L., Silva-Cardoso J., Sliwa K., Temizhan A., Teo K.K., Wittlinger T., Yusuf S.Fuentes:googlescopusLowering cholesterol, blood pressure, or both to prevent cardiovascular events: Results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants
ArticleAbstract: Aims: Rosuvastatin (10 mg per day) compared with placebo reduced major adverse cardiovascular (CV) ePalabras claves:Cardiovascular disease, Primary Prevention, statinsAutores:Avezum A.J., Bosch J.J., Dagenais G.R., Dans A.M., DIaz R., Held C., Jansky P., Joseph P.G., Jung H., Keltai K., Keltai M., Khunti K., Leiter L.A., Lewis B.S., Liu L., Lonn E.M., Pais P., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Peters R.J.G., Piegas L.S., Reid C.M., Sliwa K., Toff W.D., Varigos J.D., Xavier D., Yusoff K., Yusuf S., Zhu J.Fuentes:googlescopusVariations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study
ArticleAbstract: Background: Some studies, mainly from high-income countries (HICs), report that women receive less cPalabras claves:Autores:Alhabib K.F., Anand S.S., Bahonar A., Chifamba J., Chow C.K., Dans A.M., Davletov K., DIaz R., Didkowska J.A., Felix Camilo, Irazola V.E., Joseph P.G., Kaur M., Khatib R., Lanas F.T., Lear S.A., Liu X., Mańczuk M., Miranda J.J., Oguz A., Pérez-Mayorga M., Poirier P., Rangarajan S., Rosengren A., Rosnah I., Szuba A., Teo K.K., Tsolekile L.P., Varma R.P., Walli-Attaei M., Wei L., Yeates K.E., Yusuf R., Yusuf S., Yusufali A.M.Fuentes:googlescopusVitamin D supplementation and adverse skeletal and non-skeletal outcomes in individuals at increased cardiovascular risk: Results from the International Polycap Study (TIPS)-3 randomized controlled trial
ArticleAbstract: Background and aims: Vitamin D has mostly been tested in Western populations. We examined the effectPalabras claves:Cáncer, Cardiovascular disease, death, Falls, fractures, vitamin DAutores:Bosch J., Christou C., Dagenais G.R., Dans A.M., Gamra H., Gao P., Joseph P.G., Pais P., PATRICIO LOPEZ -JARAMILLO, Santoso A., Talukder S.H., Teo K., Tyrwhitt J., Xavier D., Yusoff K., Yusuf S.Fuentes:googlescopusRisk factors, cardiovascular disease, and mortality in South America: a PURE substudy
ArticleAbstract: Aims: In a multinational South American cohort, we examined variations in CVD incidence and mortalitPalabras claves:Cardiovascular disease, Mortality , SOUTH AMERICAAutores:Avezum A.J., Camacho-López P.A., DIaz R., Islam S., Joseph P.G., Lanas F., López-López J.P., Oliveira G.B.F., Orlandini A., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Seron P., Yusuf S.Fuentes:googlescopusPrognostic validation of a non-laboratory and a laboratory based cardiovascular disease risk score in multiple regions of the world
ArticleAbstract: Objective To evaluate the performance of the non-laboratory INTERHEART risk score (NL-IHRS) to pbkp_Palabras claves:Cardiovascular disease, INTERHEART risk score, risk pbkp_redictionAutores:Anand S.S., Avezum A.J., Chifamba J., DIaz R., Gulec S., Guo B., Gupta R., Ibrahim Q., Iqbal R., Joseph P.G., Krishnapillai A., Kruger A., Kumar R., Lanas F., Lear S.A., Lee S.F., Liu X., Mohammadifard N., Mohan V., Mony P.K., PATRICIO LOPEZ -JARAMILLO, Pillai R.K., Rangarajan S., Rosengren A., Szuba A., Teo K.K., Yang Y., Yusuf R., Yusuf S., Yusufali A.M., Zhao W.Fuentes:googlescopusPolypill with or without aspirin in persons without cardiovascular disease
ArticleAbstract: BACKGROUND A polypill comprising statins, multiple blood-pressure-lowering drugs, and aspirin has bePalabras claves:Autores:Bosch J.J., Christou C., Dagenais G.R., Dans A.M., Gamra H., Gao P., Girish P., Joseph P.G., McCready T., Pais P., PATRICIO LOPEZ -JARAMILLO, Rocha C., Santoso A., Talukder S.H., Teo K.K., Tyrwhitt J., Xavier D., Xavier F., Yeates K.E., Yusoff K., Yusuf S.Fuentes:googlescopus